Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The new version updates the study status. It also revises the Contacts/Locations section, altering location entries and contact details.
    Difference
    0.1%
    Check dated 2025-11-03T13:16:29.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    10%
    Check dated 2025-10-06T04:15:56.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page’s versioning/metadata was updated to v3.1.0 with a new date and study status entry, while an older date and version (v3.0.2) were removed. Overall, core content remains unchanged.
    Difference
    1%
    Check dated 2025-09-28T23:37:46.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.6%
    Check dated 2025-09-14T09:54:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-07T07:46:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.
    Difference
    32%
    Check dated 2025-08-31T00:55:05.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.